Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Kivu Bioscience Inc.
Hoffmann-La Roche
Institut Bergonié
Aveni Foundation
Bayer
ViroMissile, Inc.
Dana-Farber Cancer Institute
AstraZeneca
Essen Biotech
Angiex, Inc.
St. Jude Children's Research Hospital
MacroGenics
City of Hope Medical Center
University of Nebraska
Adela, Inc
Memorial Sloan Kettering Cancer Center
Var2 Pharmaceuticals
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Bristol-Myers Squibb
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
AVM Biotechnology Inc
Travera Inc
Washington University School of Medicine
GONGCHU Biotechnology Co., Ltd
Lantheus Medical Imaging
Jonsson Comprehensive Cancer Center
Azienda Ospedaliera di Padova
University of Pittsburgh
NextPoint Therapeutics, Inc.
Cancer Research UK
Tempus AI
Elevation Oncology
Stanford University
Labcorp Corporation of America Holdings, Inc
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
Stanford University
Cybrexa Therapeutics
Agenus Inc.
Cyteir Therapeutics, Inc.
Actuate Therapeutics Inc.
Shanghai PerHum Therapeutics Co., Ltd.
Peking University
European Organisation for Research and Treatment of Cancer - EORTC
NantCell, Inc.
Zhejiang Provincial People's Hospital
Xencor, Inc.